Blood Levels of Local Anaesthetic in Knee Arthroplasty
Blood Levels of Local Anaesthetic in Knee Arthroplasty: A Pharmacological Study of Ropivacaine Blood Levels During the Caledonian Technique for Knee Arthroplasty
  • Phase

  • Study Type

  • Status

    Completed No Results Posted
  • Study Participants

The primary goal is to evaluate ropivacaine blood concentrations during and after local anaesthetic (ropivacaine) infiltration - the Caledonian technique - for total knee replacement surgery. The investigators plan to measure these levels by testing blood samples taken over a timed period.

This will allow us to confirm whether the current regimen of local anaesthetic use is within safe limits.
Local anaesthetic (LA) toxicity may occur when the blood levels of a drug become particularly high. There is a need to confirm that the technique is safe to use. In addition, journal case reports may only describe serious side-effects of toxicity such as abnormal heart rhythms whilst more subtle clinical signs are rarely reported.

The investigators would like to study whether or not toxic levels may be approached in some patients or whether more subtle toxicity symptoms and signs are missed. For example, irregular heartbeat, low blood pressure or confusion/agitation.

Therefore, the investigators intend to study ropivacaine blood levels in patients receiving a total knee replacement in the Golden Jubilee National Hospital. A series of timed samples will be taken during the perioperative period. The anaesthesia and surgery will be performed as routine and no new treatment will be involved. Patient demographics, ropivacaine blood levels and clinical observations following LA administration will be collected.
Study Started
Aug 31
Primary Completion
Jan 31
Study Completion
Jan 31
Last Update
Jun 11

Drug Ropivacaine

  • Other names: Naropin

Ropivacaine None

Injection of local anaesthetic (ropivacaine) into the knee joint following knee arthroplasty. Total dose 200mls of 0.2% ropivacaine or 400mg at the time of surgery plus up to 5 top-up boluses (40mls of 0.2% ropivacaine or 80mg) postoperatively.


Patients undergoing elective knee joint replacement where they will be receiving the Caledonian technique


Inclusion Criteria:

Male or female patients greater than 65 years of age

Exclusion Criteria:

Patients with a known sensitivity/allergy to ropivacaine or amide-type local anaesthetics
Patients who are not suitable for the Caledonian technique
Patients who refuse or are unable to give consent
Patients undergoing bilateral hip replacements
Patients with known heart, liver or kidney failure
No Results Posted